Novo Nordisk's pricing techniques in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of rate gouging, declaring the stark contrast between U.S. selling prices and people in Europe and copyright.The manufacturer suggests that right usage of copyright, along with diet regime and work out, "may well